GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Healios KK (FRA:6VX) » Definitions » EV-to-Revenue

Healios KK (FRA:6VX) EV-to-Revenue : 83.65 (As of Jun. 02, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Healios KK EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Healios KK's enterprise value is €264.91 Mil. Healios KK's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was €3.17 Mil. Therefore, Healios KK's EV-to-Revenue for today is 83.65.

The historical rank and industry rank for Healios KK's EV-to-Revenue or its related term are showing as below:

FRA:6VX' s EV-to-Revenue Range Over the Past 10 Years
Min: -6870.61   Med: 790.66   Max: 13102.28
Current: 80.89

During the past 11 years, the highest EV-to-Revenue of Healios KK was 13102.28. The lowest was -6870.61. And the median was 790.66.

FRA:6VX's EV-to-Revenue is ranked worse than
84.45% of 997 companies
in the Biotechnology industry
Industry Median: 7.4 vs FRA:6VX: 80.89

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-02), Healios KK's stock price is €2.66. Healios KK's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was €0.03. Therefore, Healios KK's PS Ratio for today is 78.24.


Healios KK EV-to-Revenue Historical Data

The historical data trend for Healios KK's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healios KK EV-to-Revenue Chart

Healios KK Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,670.89 1,648.56 186.23 83.65 26.75

Healios KK Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.65 83.04 27.49 26.75 46.06

Competitive Comparison of Healios KK's EV-to-Revenue

For the Biotechnology subindustry, Healios KK's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healios KK's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Healios KK's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Healios KK's EV-to-Revenue falls into.


;
;

Healios KK EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Healios KK's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=264.909/3.167
=83.65

Healios KK's current Enterprise Value is €264.91 Mil.
Healios KK's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Healios KK  (FRA:6VX) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Healios KK's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2.66/0.034
=78.24

Healios KK's share price for today is €2.66.
Healios KK's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Healios KK EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Healios KK's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Healios KK Business Description

Traded in Other Exchanges
Address
World Trade Center Bldg. 15th Floor, 2-4-1 Hamamatsucho, Minato-ku, Tokyo, JPN, 105-6115
Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy.

Healios KK Headlines

No Headlines